First results from the phase 3 CheckMate 274 trial of adjuvant nivolumab vs placebo in patients who underwent radical surgery for high-risk muscle-invasive urothelial carcinoma (MIUC)

Autor: Bajorin, Dean F. Witjes, Johannes Alfred Gschwend, Jurgen and Schenker, Michael Valderrama, Begona P. Tomita, Yoshihiko and Bamias, Aristotelis Lebret, Thierry Shariat, Shahrokh Park, Se Hoon Ye Dingwei Agerbaek, Mads Collette, Sandra and Unsal-Kacmaz, Keziban Zardavas, Dimitrios Koon, Henry B. and Galsky, Matt D.
Jazyk: angličtina
Rok vydání: 2021
Databáze: OpenAIRE
Externí odkaz: